SCHEMBL3898768

SCHEMBL3898768

Cc1ccc(S(=O)(=O)n2ccc3ccc(C#C[Si](C)(C)C)cc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
HTT P42858 3/20 0.40
RAPGEF4 Q8WZA2 2/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DRD2 P14416 2/20 0.40
HTR2A P28223 1/20 0.40
HTR7 P34969 1/20 0.40
HTR1A P08908 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14722247 0.82 HTR6 (0.48) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL5922702 0.82 HTR6 (0.48) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL6733104 0.80 HTR6 (0.58) HTR6L3MBTL1MEN1KMT2AHTT
SCHEMBL1898211 0.80 HTR6 (0.56) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL1306928 0.75 HTR6 (0.54) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL29408218 0.75 MEN1 (0.60) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL1892821 0.75 HTR6 (0.54) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL2573218 0.75 MEN1 (0.60) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL17049296 0.75 HTR6 (0.51) HTR6L3MBTL1MEN1KMT2ASLC1A3
SCHEMBL30669307 0.74 HTR6 (0.50) HTR6L3MBTL1MEN1KMT2ASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654251-A4 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2009-03-11 EP disclosed
US-20060205740-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2006-09-14 US disclosed
EP-1654251-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-05-10 EP disclosed
WO-2005016914-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205740-A1 Chemical compounds ERBB2, ERBB4, ERBB3 HTR6 2297/4885L3MBTL1 4480/4885MEN1 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.